Breast cancers that occur in women 2–5 years postpartum are more frequently diagnosed at metastatic stages and correlate with poorer outcomes compared with breast cancers diagnosed in young, premenopausal women. The molecular mechanisms underlying the malignant severity associated with postpartum breast cancers (ppBCs) are unclear but relate to stromal wound-healing events during postpartum involution, a dynamic process characterized by widespread cell death in milk-producing mammary epithelial cells (MECs). Using both spontaneous and allografted mammary tumors in fully immune–competent mice, we discovered that postpartum involution increases mammary tumor metastasis. Cell death was widespread, not only occurring in MECs but also in tumor epithelium. Dying tumor cells were cleared through receptor tyrosine kinase MerTK–dependent efferocytosis, which robustly induced the transcription of genes encoding wound-healing cytokines, including IL-4, IL-10, IL-13, and TGF-β. Animals lacking MerTK and animals treated with a MerTK inhibitor exhibited impaired efferocytosis in postpartum tumors, a reduction of M2-like macrophages but no change in total macrophage levels, decreased TGF-β expression, and a reduction of postpartum tumor metastasis that was similar to the metastasis frequencies observed in nulliparous mice. Moreover, TGF-β blockade reduced postpartum tumor metastasis. These data suggest that widespread cell death during postpartum involution triggers efferocytosis-induced wound-healing cytokines in the tumor microenvironment that promote metastatic tumor progression.
Jamie C. Stanford, Christian Young, Donna Hicks, Philip Owens, Andrew Williams, David B. Vaught, Meghan M. Morrison, Jiyeon Lim, Michelle Williams, Dana M. Brantley-Sieders, Justin M. Balko, Debra Tonetti, H. Shelton Earp III, Rebecca S. Cook
Title and authors | Publication | Year |
---|---|---|
Efferocytosis: The Janus‐Faced Gatekeeper of Aging and Tumor Fate
Liu Z, Li Y, Ren Y, Chen J, Weng S, Zhou Z, Luo P, Chen Q, Xu H, Ba Y, Zuo A, Liu S, Zhang Y, Pan T, Han X |
Aging Cell | 2025 |
Proteolysis of TAM receptors in autoimmune diseases and cancer: what does it say to us?
Malikova I, Worth A, Aliyeva D, Khassenova M, Kriajevska MV, Tulchinsky E |
Cell Death & Disease | 2025 |
Reproductive state controls transcription in the murine liver, with implications for breast cancer liver metastasis
Ozaki MK, Zhang Y, Bartlett AQ, de Wilde E, Guan X, Yang A, Xia Z, Schedin P |
Proceedings of the National Academy of Sciences of the United States of America | 2025 |
A Bispecific Modeling Framework Enables the Prediction of Efficacy, Toxicity, and Optimal Molecular Design of Bispecific Antibodies Targeting MerTK.
Li R, Dere E, Kwong M, Fei M, Dave R, Masih S, Wang J, McNamara E, Huang H, Liang WC, Schutt L, Kamath AV, Ovacik MA |
The AAPS Journal | 2024 |
Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy.
Hu Y, Revenko A, Barsoumian H, Bertolet G, Fowlkes NW, Maazi H, Green MM, He K, Sezen D, Voss TA, Leyton CSK, Masrorpour F, Rafiq Z, Puebla-Osorio N, Leuschner C, MacLeod R, Cortez MA, Welsh JW |
Journal of experimental & clinical cancer research : CR | 2024 |
Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing
Lahey KC, Varsanyi C, Wang Z, Aquib A, Gadiyar V, Rodrigues AA, Pulica R, Desind S, Davra V, Calianese DC, Liu D, Cho JH, Kotenko SV, De Lorenzo MS, Birge RB |
International journal of molecular sciences | 2024 |
Progress of research on the relationship between efferocytosis and tumor
Yao X, Zhang L, Sun S, Fu A, Ge Y |
Frontiers in Oncology | 2024 |
Efferocytosis by macrophages in physiological and pathological conditions: regulatory pathways and molecular mechanisms
Sheng Y, Hu W, Chen S, Zhu X |
Frontiers in immunology | 2024 |
In the Eyes of the Beholder—New Mertk Knockout Mouse and Re-Evaluation of Phagocytosis versus Anti-Inflammatory Functions of MERTK
Ghosh S, Finnemann SC, Vollrath D, Rothlin CV |
International journal of molecular sciences | 2024 |
Osteopontin regulation of MerTK+ macrophages promotes Crohn’s disease intestinal fibrosis
Liu J, Gong W, Liu P, Li Y, Jiang H, Wu C, Wu X, Zhao Y, Ren J |
iScience | 2024 |
CD9 and Aryl Hydrocarbon Receptor Are Markers of Human CD19+CD14+ Atypical B Cells and Are Dysregulated in Systemic Lupus Erythematous Disease.
Blevins LK, Khan DMIO, Crawford RB, O'Neill C, Bach AP, Zhou J, Karmaus PW, Ang DC, Thapa R, Kaminski NE |
Journal of immunology (Baltimore, Md. : 1950) | 2024 |
MERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunity.
Huelse JM, Bhasin SS, Jacobsen KM, Yim J, Thomas BE, Branella GM, Bakhtiari M, Chimenti ML, Baxter TA, Raikar SS, Wang X, Frye SV, Henry CJ, Earp HS, Bhasin M, DeRyckere D, Graham DK |
Leukemia | 2024 |
Phosphatidylserine externalization as immune checkpoint in cancer.
Kur IM, Weigert A |
Pflugers Archiv : European journal of physiology | 2024 |
Control of tumor-associated macrophage responses by nutrient acquisition and metabolism.
Zhang X, Ji L, Li MO |
Immunity | 2023 |
Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment
Cruz Cruz J, Allison KC, Page LS, Jenkins AJ, Wang X, Earp HS, Frye SV, Graham DK, Verneris MR, Lee-Sherick AB |
Frontiers in immunology | 2023 |
Cell death, therapeutics, and the immune response in cancer
Hänggi K, Ruffell B |
Trends in Cancer | 2023 |
Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Reveals That TAM2-Driven Genes Affect Immunotherapeutic Response and Prognosis in Pancreatic Cancer.
Du Y, Dong S, Jiang W, Li M, Li W, Li X, Zhou W |
International journal of molecular sciences | 2023 |
Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.
Myers Chen KV, de Groot AE, Mendez SA, Mallin MM, Amend SR, Pienta KJ |
Medical Oncology | 2023 |
TAM family kinases as therapeutic targets at the interface of cancer and immunity.
DeRyckere D, Huelse JM, Earp HS, Graham DK |
Nature reviews. Clinical oncology | 2023 |
Interface between Resolvins and Efferocytosis in Health and Disease.
Mohammad-Rafiei F, Negahdari S, Tahershamsi Z, Gheibihayat SM |
Cell Biochemistry and Biophysics | 2023 |
The Prognosis of Cancer Depends on the Interplay of Autophagy, Apoptosis, and Anoikis within the Tumor Microenvironment.
Gulia S, Chandra P, Das A |
Cell Biochemistry and Biophysics | 2023 |
Hijacking homeostasis: Regulation of the tumor microenvironment by apoptosis
Gregory CD |
Immunological Reviews | 2023 |
The role of phosphatidylserine on the membrane in immunity and blood coagulation
J Wang, C Yu, J Zhuang, W Qi, J Jiang, X Liu, W Zhao, Y Cao, H Wu, J Qi, R Zhao |
Biomarker Research | 2022 |
MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression
J Lin, A Xu, J Jin, M Zhang, J Lou, C Qian, J Zhu, Y Wang, Z Yang, X Li, W Yu, B Liu, H Tao |
OncoImmunology | 2022 |
The Apoptosis Paradox in Cancer
O Morana, W Wood, C Gregory |
International journal of molecular sciences | 2022 |
Phosphatidylserine released from apoptotic cells in tumor induces M2‐like macrophage polarization through the PSR‐STAT3‐JMJD3 axis
X Liang, M Luo, B Shao, J Yang, A Tong, R Wang, Y Liu, R Jun, T Liu, T Yi, X Zhao, Y Wei, X Wei |
2022 | |
The immune environment of the mammary gland fluctuates during post-lactational regression and correlates with tumour growth rate
Hitchcock J, Hughes K, Pensa S, Lloyd-Lewis B, Watson CJ |
Development (Cambridge, England) | 2022 |
Which Has a Greater Impact on the Recurrence in Young Breast Cancer Patients: Recent Childbirth or Recent Breastfeeding?
Yan C, Bai J, Bao S, Xia Y, Yu H, Yin Y |
The Breast Journal | 2022 |
BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity.
Bae SH, Kim JH, Park TH, Lee K, Lee BI, Jang H |
Experimental & molecular medicine | 2022 |
Tissue-specific modifier alleles determine Mertk loss-of-function traits.
Akalu YT, Mercau ME, Ansems M, Hughes LD, Nevin J, Alberto EJ, Liu XN, He LZ, Alvarado D, Keler T, Kong Y, Philbrick WM, Bosenberg M, Finnemann SC, Iavarone A, Lasorella A, Rothlin CV, Ghosh S |
eLife | 2022 |
Efferocytosis drives myeloid NLRP3 dependent inflammasome signaling secretion of IL-1β to promote tumor growth
Lang C, Roy S, Wang Y, Graves D, Xu Y, Serezani CH, Korrer M, Kim YJ |
Frontiers in immunology | 2022 |
Bone Marrow Macrophages Induce Inflammation by Efferocytosis of Apoptotic Prostate Cancer Cells via HIF-1α Stabilization
Mendoza-Reinoso V, Schnepp PM, Baek DY, Rubin JR, Schipani E, Keller ET, McCauley LK, Roca H |
Cells | 2022 |
Metabolic disorders sensitise endometrial carcinoma through endoplasmic reticulum stress.
Zhou J, Lin Y, Yang X, Shen B, Hao J, Wang J, Wang J |
Cellular & Molecular Biology Letters | 2022 |
Dual targeting of TAM receptors Tyro3, Axl, and MerTK: Role in tumors and the tumor immune microenvironment
KH Wang, DC Ding |
Tzu Chi Medical Journal | 2021 |
Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes
S Jindal, ND Pennock, D Sun, W Horton, MK Ozaki, J Narasimhan, AQ Bartlett, S Weinmann, PE Goss, VF Borges, Z Xia, P Schedin |
Nature Communications | 2021 |
Reprograming of Tumor-Associated Macrophages in Breast Tumor-Bearing Mice under Chemotherapy by Targeting Heme Oxygenase-1
SH Kim, SJ Kim, J Park, Y Joe, SE Lee, S Saeidi, X Zhong, SH Kim, SA Park, HK Na, HT Chung, YJ Surh |
Antioxidants | 2021 |
Unique Pro-Inflammatory Response of Macrophages during Apoptotic Cancer Cell Clearance
V Mendoza-Reinoso, DY Baek, A Kurutz, JR Rubin, AJ Koh, LK McCauley, H Roca |
Cells | 2020 |
Lifting the innate immune barriers to antitumor immunity
CV Rothlin, S Ghosh |
Journal for ImmunoTherapy of Cancer | 2020 |
The role of phosphatidylserine recognition receptors in multiple biological functions
MB Naeini, V Bianconi, M Pirro, A Sahebkar |
Cellular & Molecular Biology Letters | 2020 |
Measurement and models accounting for cell death capture hidden variation in compound response
SY Bae, N Guan, R Yan, K Warner, SD Taylor, AS Meyer |
Cell Death and Disease | 2020 |
Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer
AD Mahapatra, R Choubey, B Datta |
Molecules (Basel, Switzerland) | 2020 |
LC3-Associated Phagocytosis (LAP): A Potentially Influential Mediator of Efferocytosis-Related Tumor Progression and Aggressiveness
PF Asare, E Roscioli, PR Hurtado, HB Tran, CY Mah, S Hodge |
Frontiers in Oncology | 2020 |
Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC
P Giroud, S Renaudineau, L Gudefin, A Calcei, T Menguy, C Rozan, J Mizrahi, C Caux, V Duong, J Valladeau-Guilemond |
Frontiers in immunology | 2020 |
Cell Death in the Tumor Microenvironment: Implications for Cancer Immunotherapy
V Gadiyar, KC Lahey, D Calianese, C Devoe, D Mehta, K Bono, S Desind, V Davra, RB Birge |
Cells | 2020 |
A Potent and Selective Dual Inhibitor of AXL and MERTK Possesses Both Immunomodulatory and Tumor-Targeted Activity
J Rios-Doria, M Favata, K Lasky, P Feldman, Y Lo, G Yang, C Stevens, X Wen, S Sehra, K Katiyar, K Liu, R Wynn, JJ Harris, M Ye, S Spitz, X Wang, C He, YL Li, W Yao, M Covington, P Scherle, H Koblish |
Frontiers in Oncology | 2020 |
Efferocytosis and Its Associated Cytokines: A Light on Non-tumor and Tumor Diseases?
D Lin, X Kang, L Shen, S Tu, C Lenahan, Y Chen, X Wang, A Shao |
Molecular Therapy — Oncolytics | 2020 |
Cancer Cells and M2 Macrophages: Cooperative Invasive Ecosystem Engineers
KV Myers, KJ Pienta, SR Amend |
Cancer control : journal of the Moffitt Cancer Center | 2020 |
Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy
SJ Wang, R Li, TS Ng, G Luthria, MJ Oudin, M Prytyskach, RH Kohler, R Weissleder, DA Lauffenburger, MA Miller |
Science Advances | 2020 |
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis
M Donadon, G Torzilli, N Cortese, C Soldani, LD Tommaso, B Franceschini, R Carriero, M Barbagallo, A Rigamonti, A Anselmo, FS Colombo, G Maggi, A Lleo, J Cibella, C Peano, P Kunderfranco, M Roncalli, A Mantovani, F Marchesi |
Journal of Experimental Medicine | 2020 |
Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer.
Dimou A, Nasarre C, Peterson YK, Pagano R, Gooz M, Nasarre P, Drabkin HA, Armeson KE, Gibney BC, Gemmill RM, Denlinger CE |
The Journal of Thoracic and Cardiovascular Surgery | 2020 |
MERTK in Cancer Therapy: Targeting the Receptor Tyrosine Kinase in Tumor Cells and the Immune System
Huelse J, Fridlyand D, Earp S, DeRyckere D, Graham DK |
Pharmacology & Therapeutics | 2020 |
Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology
S Morioka, C Maueröder, KS Ravichandran |
Immunity | 2019 |
Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor X Bai, M Yi, Y Jiao, Q Chu, K Wu |
OncoTargets and therapy | 2019 |
Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
KV Myers, SR Amend, KJ Pienta |
Molecular Cancer | 2019 |
MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation
C Nishi, Y Yanagihashi, K Segawa, S Nagata |
The Journal of biological chemistry | 2019 |
Gas6/MerTK signaling is negatively regulated by NF-κB and supports lung carcinogenesis
SV Novitskiy, R Zaynagetdinov, G Vasiukov, S Gutor, W Han, A Serezani, A Matafonov, LA Gleaves, TP Sherrill, VV Polosukhin, TS Blackwell |
Oncotarget | 2019 |
Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor
A Gartung, J Yang, VP Sukhatme, DR Bielenberg, D Fernandes, J Chang, BA Schmidt, SH Hwang, D Zurakowski, S Huang, MW Kieran, BD Hammock, D Panigrahy |
Proceedings of the National Academy of Sciences | 2019 |
Therapeutic inhibition of Mcl-1 blocks cell survival in estrogen receptor-positive breast cancers.
Williams MM, Elion DL, Rahman B, Hicks DJ, Sanchez V, Cook RS |
Oncotarget | 2019 |
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity
Alisa Lee Sherick, Kristen M Jacobsen, Curtis Henry, Madeline G Huey, Rebecca E. Parker, Lauren Page, Amanda A Hill, Xiaodong Wang, Stephen Frye, Shelton Earp, Craig T. Jordan, Deborah DeRyckere, Douglas K. Graham |
JCI Insight | 2018 |
Tumor-Secreted Pros1 Inhibits Macrophage M1 Polarization to Reduce Anti-Tumor Immune Response
Eric Ubil, Laura Caskey, Alisha Holtzhausen, Debra Hunter, Charlotte Story, Shelton Earp |
Journal of Clinical Investigation | 2018 |
Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions
S Roy, AK Bag, S Dutta, NS Polavaram, R Islam, S Schellenburg, J Banwait, C Guda, S Ran, MA Hollingsworth, RK Singh, JE Talmadge, MH Muders, SK Batra, K Datta |
Cancer research | 2018 |
Repeated exposure of epithelial cells to apoptotic cells induces the specific selection of an adaptive phenotype: Implications for tumorigenesis
L Feng, S Vujicic, ME Dietrich, N Litbarg, S Setty, A Antoni, J Rauch, JS Levine |
The Journal of biological chemistry | 2018 |
Exploitation of Apoptotic Regulation in Cancer
DS Ucker, JS Levine |
Frontiers in immunology | 2018 |
Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin
J Chang, SS Bhasin, DR Bielenberg, VP Sukhatme, M Bhasin, S Huang, MW Kieran, D Panigrahy |
The FASEB Journal | 2018 |
Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer
ND Pennock, HA Martinson, Q Guo, CB Betts, S Jindal, T Tsujikawa, LM Coussens, VF Borges, P Schedin |
Journal for ImmunoTherapy of Cancer | 2018 |
Targeting tumour microenvironment by tyrosine kinase inhibitor
HY Tan, N Wang, W Lam, W Guo, Y Feng, YC Cheng |
Molecular Cancer | 2018 |
Efferocytosis in the tumor microenvironment
TA Werfel, RS Cook |
Seminars in Immunopathology | 2018 |
The Mammary Microenvironment in Mastitis in Humans, Dairy Ruminants, Rabbits and Rodents: A One Health Focus
K Hughes, CJ Watson |
Journal of Mammary Gland Biology and Neoplasia | 2018 |
The Multifaceted Role of STAT3 in Mammary Gland Involution and Breast Cancer
K Hughes, C Watson |
International journal of molecular sciences | 2018 |
Impaired efferocytosis by monocytes in multiple myeloma
Y Liang, I Schwarzinger, I SimonitschKlupp, H Agis, R Oehler |
Oncology Letters | 2018 |
Autophagy and unfolded protein response (UPR) regulate mammary gland involution by restraining apoptosis-driven irreversible changes
A Wärri, KL Cook, R Hu, L Jin, A Zwart, DR Soto-Pantoja, J Liu, T Finkel, R Clarke |
Cell Death Discovery | 2018 |
Efferocytosis and prostate cancer skeletal metastasis: implications for intervention.
Roca H, McCauley LK |
Oncoscience | 2018 |
Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone
Hernan Roca, Jacqueline Jones, Marta Purica, Savannah Weidner, Amy Koh, Robert Kuo, John Wilkinson, Yugang Wang, Stephanie Daignault, Kenneth Pienta, Todd Morgan, Evan Keller, Jacques Nor, Lonnie Shea, Laurie mccauley |
Journal of Clinical Investigation | 2017 |
S1P Provokes Tumor Lymphangiogenesis via Macrophage-Derived Mediators Such as IL-1 β or Lipocalin-2
SN Syed, M Jung, A Weigert, B Brüne |
Mediators of Inflammation | 2017 |
TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy
YT Akalu, CV Rothlin, S Ghosh |
Immunological Reviews | 2017 |
Mammary Gland Involution Provides a Unique Model to Study the TGF-β Cancer Paradox
Q Guo, C Betts, N Pennock, E Mitchell, P Schedin |
Journal of Clinical Medicine | 2017 |
Iron Handling in Tumor-Associated Macrophages—Is There a New Role for Lipocalin-2?
M Jung, A Weigert, C Mertens, C Rehwald, B Brüne |
Frontiers in immunology | 2017 |
Editorial: How Reproductive History Influences Our Breast Cancer Risk
RL Anderson, WV Ingman, KL Britt |
Frontiers in Oncology | 2017 |
Antagonistic Coevolution of MER Tyrosine Kinase Expression and Function
AL Evans, JW Blackburn, K Taruc, A Kipp, BS Dirk, NR Hunt, SD Barr, JD Dikeakos, B Heit |
Molecular Biology and Evolution | 2017 |
MUC1 induces M2 type macrophage influx during postpartum mammary gland involution and triggers breast cancer
Y Li, Z Pang, X Dong, X Liao, H Deng, C Liao, Y Liao, G Chen, L Huang |
Oncotarget | 2017 |
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer
RB Birge, S Boeltz, S Kumar, J Carlson, J Wanderley, D Calianese, M Barcinski, RA Brekken, X Huang, JT Hutchins, B Freimark, C Empig, J Mercer, AJ Schroit, G Schett, M Herrmann |
Cell Death and Differentiation | 2016 |
Deciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast Cancer
VF Borges, AM Elder, TR Lyons |
Frontiers in Oncology | 2016 |
A fate worse than death: apoptosis as an oncogenic process
G Ichim, SW Tait |
Nature Reviews Cancer | 2016 |
Rab17 mediates differential antigen sorting following efferocytosis and phagocytosis
C Yin, Y Kim, D Argintaru, B Heit |
Cell Death and Disease | 2016 |
Myeloid-Epithelial-Reproductive Receptor Tyrosine Kinase and Milk Fat Globule Epidermal Growth Factor 8 Coordinately Improve Remodeling After Myocardial Infarction via Local Delivery of Vascular Endothelial Growth FactorCLINICAL PERSPECTIVE
KY Howangyin, I Zlatanova, C Pinto, A Ngkelo, C Cochain, M Rouanet, J Vilar, M Lemitre, C Stockmann, BK Fleischmann, Z Mallat, JS Silvestre |
Circulation | 2016 |
The Dynamics of Apoptotic Cell Clearance
MR Elliott, KS Ravichandran |
Developmental Cell | 2016 |
Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response
V Davra, S Kimani, D Calianese, R Birge |
Cancers | 2016 |
Efferocytosis in oral squamous cell carcinoma
GS Sarode |
Journal of Oral and Maxillofacial Pathology : JOMFP | 2016 |
Non-Canonical Cell Death Induced by p53
A Ranjan, T Iwakuma |
International journal of molecular sciences | 2016 |
Oncogenic Properties of Apoptotic Tumor Cells in Aggressive B Cell Lymphoma
CA Ford, S Petrova, JD Pound, JJ Voss, L Melville, M Paterson, SL Farnworth, AM Gallimore, S Cuff, H Wheadon, E Dobbin, CA Ogden, IE Dumitriu, DR Dunbar, PG Murray, D Ruckerl, JE Allen, DA Hume, N van Rooijen, JR Goodlad, TC Freeman, CD Gregory |
Current Biology | 2015 |
ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis
M Yang, J Liu, C Piao, J Shao, J Du |
Cell Death and Disease | 2015 |
Discovering Molecules That Regulate Efferocytosis Using Primary Human Macrophages and High Content Imaging
S Santulli-Marotto, A Gervais, J Fisher, B Strake, CA Ogden, C Riveley, J Giles-Komar, N Palaniyar |
PloS one | 2015 |
Mammary epithelial cell phagocytosis downstream of TGF-β3 is characterized by adherens junction reorganization
J Fornetti, KC Flanders, PM Henson, AC Tan, VF Borges, P Schedin |
Cell Death and Differentiation | 2015 |
Clearance of dying cells accelerates malignancy
DB Vaught, RS Cook |
Oncotarget | 2015 |
Efferocytosis creates a tumor microenvironment supportive of tumor survival and metastasis.
Vaught DB, Stanford JC, Cook RS |
Cancer Cell & Microenvironment | 2015 |
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
DK Graham, D DeRyckere, KD Davies, HS Earp |
Nature Reviews Cancer | 2014 |